RTH258

brolucizumab · Novartis

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for RTH258, covering 2019-10-31 to 2019-10-31. Get the full timeline:

Most recent: Clinical Trial Update: Efficacy and Safety of RTH258 Versus Aflibercept - Study 2 [Phase 3]